Eye Diseases Clinical Trial
Official title:
A Prospective Observational Study to Investigate the Role of the Biomechanics of the Cornea in Identifying Glaucoma or Anterior Eye Diseases and Create an IT Tool Able to Distinguish Between Them
NCT number | NCT05973617 |
Other study ID # | 005-2021-SN |
Secondary ID | |
Status | Withdrawn |
Phase | |
First received | |
Last updated | |
Start date | December 2022 |
Est. completion date | June 2023 |
Verified date | August 2023 |
Source | Aston University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of the study is to use machine learning to develop an IT tool able to differentiate between eye conditions analysing corneal biomechanical data.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | June 2023 |
Est. primary completion date | June 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age above 18 years old. - Participants who are able to give informed consent. - Study groups: Patients with diagnosis of glaucoma or corneal disease or ocular hypertension. Patients that are having a treatment (medications or surgery) for glaucoma or ocular hypertension or corneal conditions. - Control group: people with no diagnosis or treatment of previous pathologies. Exclusion Criteria: - Age below 18. - Participants who are not able to give informed consent. - Patients with eye conditions not within the inclusion criteria. - Patients with respiratory distress or significant head tremor. - Patients who are in pain or unable to remain seated for duration of measurements. - Participants that during the visit are wearing contact lenses. The wear of contact lenses can alter the measure of corneal biomechanics. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Aston University | Sandwell & West Birmingham Hospitals NHS Trust |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | First applanation velocity | Velocity during the first applanation of the cornea, measured using Corivs ST [m/s] | Day 1 | |
Primary | First applanation time | Time frame of the first applanation of the cornea, measured using Corivs ST [s] | Day 1 | |
Primary | First applanation lenght | Lenght of the first applanation of the cornea, measured using Corivs ST [mm] | Day 1 | |
Primary | Second applanation velocity | Velocity during the second applanation of the cornea, measured using Corivs ST [m/s] | Day 1 | |
Primary | Second applanation time | Time frame of the second applanation of the cornea, measured using Corivs ST [s] | Day 1 | |
Primary | Second applanation lenght | Lenght of the second applanation of the cornea, measured using Corivs ST [mm] | Day 1 | |
Primary | Highest concavity time | Time frame at highest concavity, measured using Corivs ST [s] | Day 1 | |
Primary | Highest concavity peak distance | Distance between the 2 surrounding peaks at the highest concavity, measured using Corivs ST [mm] | Day 1 | |
Primary | Highest concavity radius | Radius of curvature at highest concavity, measured using Corivs ST [mm] | Day 1 | |
Primary | Highest concavity deformation amplitude | Maximal displacement of corneal apex between normal corneal shape and highest concavity, measured using Corivs ST [mm] | Day 1 | |
Primary | Corneal hysteresis | Difference in terms of intensity of puff of air between the first and second applanation, measured using ORA [mmHg] | Day 1 | |
Primary | Corneal resistance factor | Overall resistance of the cornea, measured using ORA [mmHg] | Day 1 | |
Secondary | Intraocular pressure measured using Corvis ST | Value of intraocular pressure measured according to the pressure of the air needed to applanate the cornea. | Day 1 | |
Secondary | Intraocular pressure measured using ORA | Value of intraocular pressure measured according to the pressure of the air needed to applanate the cornea. | Day 1 | |
Secondary | Pachymetry | Measure of corneal thickness using Corvis ST | Day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05414994 -
Assessment of the Ocular Microbiome in Health and Disease
|
||
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Completed |
NCT02811692 -
Study for Collection of Aflibercept Data in Routine Practice
|
||
Recruiting |
NCT06045299 -
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
|
Phase 3 | |
Recruiting |
NCT01521065 -
An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
|
Phase 2 | |
Completed |
NCT04799704 -
Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients.
|
||
Recruiting |
NCT05876689 -
Swept Source OCT Imaging With the DREAM VG-OCT
|
||
Active, not recruiting |
NCT04123626 -
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
|
Phase 1/Phase 2 | |
Recruiting |
NCT04150432 -
Correlation Between Exhaled Propofol Concentration With Plasma Concentration in Children
|
N/A | |
Not yet recruiting |
NCT05550740 -
Repeated Low-Level Red-Light Therapy for Shortening Axial Length
|
N/A | |
Completed |
NCT02332343 -
Sparing of the Fovea in Geographic Atrophy Progression
|
N/A | |
Completed |
NCT01727973 -
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
|
Phase 1/Phase 2 | |
Terminated |
NCT01225146 -
Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)
|
Phase 1 | |
Completed |
NCT00333203 -
Next Generation Ophthalmic Irrigating Solution Posterior Segment Study
|
Phase 3 | |
Not yet recruiting |
NCT05565547 -
Multimodal Equipment for Teleophthalmology Assessment (META)
|
||
Recruiting |
NCT05158699 -
Effectiveness of Periocular Drug Injection in CATaract Surgery
|
Phase 3 | |
Recruiting |
NCT06112340 -
A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
|
Phase 2/Phase 3 | |
Recruiting |
NCT06451172 -
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
|
Early Phase 1 | |
Completed |
NCT05211089 -
Manual Versus Automated Choroidal Thickness Measurements Using Swept-source Anterior Segment OCT
|
||
Not yet recruiting |
NCT06070467 -
Holistic Mixed Approaches to Capture the Real Life of Children With Rare Eye Diseases
|